A Microdose Study of TTX-MC138-NODAGA-Cu64 in Subjects With Advanced Solid Tumors
Clinical trial NCT05908773 · COMPLETED
Trial details
- NCT number
- NCT05908773
- Sponsor
- TransCode Therapeutics
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-04
- Primary completion
- 2023-08-23
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.